salbutamol cipla salbutamol 5mg/2.5ml (as sulfate) inhalation ampoules
cipla australia pty ltd - salbutamol sulfate, quantity: 6 mg (equivalent: salbutamol, qty 5 mg) - inhalation, conventional - excipient ingredients: sulfuric acid; water for injections; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.
salbutamol cipla salbutamol 2.5mg/2.5ml (as sulfate) inhalation ampoules
cipla australia pty ltd - salbutamol sulfate, quantity: 3 mg (equivalent: salbutamol, qty 2.5 mg) - inhalation, conventional - excipient ingredients: water for injections; sulfuric acid; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.
salbutamol an salbutamol (as sulfate) 5mg/2.5ml inhalation ampoules
amneal pharma australia pty ltd - salbutamol sulfate -
salbutamol an salbutamol (as sulfate) 2.5mg/2.5ml inhalation ampoules
amneal pharma australia pty ltd - salbutamol sulfate -
salbutamol sandoz salbutamol 5mg/2.5ml (as sulfate) inhalation ampoules
sandoz pty ltd - salbutamol sulfate -
salbutamol sandoz salbutamol 2.5mg/2.5ml (as sulfate) inhalation ampoules
sandoz pty ltd - salbutamol sulfate -
ventolin
glaxosmithkline nz limited - salbutamol sulfate 120.5ug equivalent to 100 µg dose (10% excess may be added to compensate for manufacturing loss); - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120.5ug equivalent to 100 µg dose (10% excess may be added to compensate for manufacturing loss) excipient: norflurane - salbutamol is a selective ?2 adrenoceptor agonist indicated for the treatment or prevention of bronchospasm. it provides short acting (four hours) bronchodilation in reversible airways obstruction due to asthma, chronic bronchitis and emphysema. for patients with asthma salbutamol may be used to relieve symptoms when they occur and to prevent them prior to a known trigger. bronchodilators should not be the only or main treatment in patients with persistent asthma. in patients with persistent asthma unresponsive to salbutamol, treatment with inhaled corticosteroids is recommended to achieve and maintain control. failure to respond promptly or fully to such rescue medication signals a need for urgent medical advice and treatment.
salbutamol k-haler
viatris limited - salbutamol sulfate 120ug equivalent to salbutamol 100 µg; - aerosol inhaler, metered dose - 100 mcg - active: salbutamol sulfate 120ug equivalent to salbutamol 100 µg excipient: ethanol norflurane oleic acid
salbutamol 4mg tablets
approved prescription services ltd - salbutamol sulfate - oral tablet - 4mg
respigen
viatris limited - salbutamol sulfate 120ug equivalent to salbutamol 100 µg; - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120ug equivalent to salbutamol 100 µg excipient: ethanol norflurane oleic acid - with its fast onset of action, it is particularly suitable for the management and prevention of attack in mild asthma and for the treatment of acute exacerbations in moderate and severe asthma.